aafq smgt-glp-1 Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products Prescription GLP-1s for Weight Loss
Description
I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)
Patients diagnosed with diabetes are initiating GLP-1 treatment more quickly than ever before Since 2021, the average time between a diabetes diagnosis and the initiation of a GLP-1 therapy has decreased by about one month, underscoring how quickly these drugs have moved to the forefront of care
Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver ...
Pre-portioned meals prevent overeating on days when appetite is unpredictable
Akkermansia muciniphila
Understanding the role of GLP-1 for weight loss is part of an integrative medicine doctor's fundamental role in treating the whole person.
